Doxercalciferol Patent Expiration
Doxercalciferol is used for managing secondary hyperparathyroidism in chronic kidney disease patients undergoing dialysis. It was first introduced by Sanofi Genzyme
Doxercalciferol Patents
Given below is the list of patents protecting Doxercalciferol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Hectorol | US7148211 | Formulation for lipophilic agents |
Sep 14, 2023
(Expired) | Sanofi |
| Hectorol | US6903083 | Stabilized hydroxyvitamin D |
Jul 18, 2021
(Expired) | Sanofi |
| Hectorol | US5602116 | Method for treating and preventing secondary hyperparathyroidism |
Feb 11, 2014
(Expired) | Sanofi |
Doxercalciferol's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List